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Abstract
The impact of ecstasy/polydrug use on real-world memory (i.e. everyday memory, cognitive failures and prospective memory [PM]) was investigated in a
sample of 42 ecstasy/polydrug users and 31 non-ecstasy users. Laboratory-based PM tasks were administered along with self-reported measures of PM to
test whether any ecstasy/polydrug-related impairment on the different aspects of PM was present. Self-reported measures of everyday memory and
cognitive failures were also administered. Ecstasy/polydrug associated deficits were observed on both laboratory and self-reported measures of PM and
everyday memory. The present study extends previous research by demonstrating that deficits in PM are real and cannot be simply attributed to
self-misperceptions. The deficits observed reflect some general capacity underpinning both time- and event-based PM contexts and are not task
specific. Among this group of ecstasy/polydrug users recreational use of cocaine was also prominently associated with PM deficits. Further research
might explore the differential effects of individual illicit drugs on real-world memory.
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Introduction
An important topic of investigation that has received increas-
ing attention in recent years concerns real-world memory pro-
cesses (i.e. everyday memory, prospective memory (PM) and
cognitive failures). Examples of everyday memory problems
and cognitive failures might include, for example, forgetting
the location of familiar objects around the house, forgetting
to take essential objects when leaving the home or oﬃce, fail-
ing to recognize acquaintances, or forgetting important events
that occurred the previous day. Prospective memory (PM)
involves remembering to execute a particular behaviour at
some point in the future, for example, remembering to
attend a meeting, meet a friend or pass on a message.
Previous investigations from our laboratory in which we eval-
uated the integrity of real-world memory processes in ecstasy/
polydrug (Montgomery and Fisk, 2007) and cannabis-only
users (Fisk and Montgomery, 2008) have shown that users
of illicit substances exhibit deﬁcits in real-world memory on a
range of measures. Evidence of ecstasy/polydrug- (Heﬀernan
et al., 2001a,b) and cannabis-related (McHale and Hunt,
2008) impairment has emerged in other studies.
Furthermore impairments may be speciﬁc to particular
drugs. For example, Rodgers and co-workers found that can-
nabis was related to short-term and internally cued PM def-
icits while ecstasy was related to deﬁcits in long-term PM
(Rodgers et al., 2001, 2003).
Most of the research into real-world memory functioning
among users of illicit substances has utilized self-reported
measures (Fisk and Montgomery, 2008; Heﬀernan et al.,
2001a,b; Montgomery and Fisk, 2007; Rodgers et al., 2001,
2003). However, it is possible that self-perceptions may be dis-
torted. For example, drug users may arrive at the laboratory
with the expectation that they will under-perform (Bedi and
Redman, 2008; Cole et al., 2006). This may aﬀect their
responses on self-reported measures causing them to imagine
or overstate the magnitude of any deﬁcits that might be pres-
ent. Clearly it would be desirable to conﬁrm the results
obtained through self-reported measures utilizing laboratory
measures of the relevant constructs. To date relatively few
studies in this area have used laboratory tests of PM. Where
such tests have been included they have been rather artiﬁcial
and contrived in nature. For example the ‘virtual week’ is a
board game completed in the laboratory in which the partici-
pant is required to complete previously learned tasks at speciﬁc
points as they progress around the board. Deﬁcits were
observed on this measure among currently abstinent ecstasy
users including those who used infrequently (Rendell et al.,
2007). While this test undoubtedly possesses a PM component
it has been acknowledged that more ecologically valid mea-
sures are needed (Will et al., 2009). In order to address some
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of these limitations, the present research will include labora-
tory measures of PM which are designed to be more natural-
istic and where the PM component is less obvious to the
participant.
Cognitive failures and PM are known to utilize prefrontal
executive processes including the working memory system.
Neuroimaging studies have revealed the involvement of the
frontopolar cortex (Brodmann area 10 [BA10]) and neigh-
bouring prefrontal areas during the performance of
PM tasks (Okuda et al., 2007). Other research utilizing
dual-task methodology (Marsh and Hicks, 1998) cognitive
ageing paradigms (McDaniel et al., 1999) and Parkinson’s-
related deﬁcits (Kliegel et al., 2005) has also linked PM func-
tioning to prefrontal lobe capacity. Therefore, if ecstasy or
other illicit drugs are associated with real-world memory def-
icits among currently abstinent users, then this would pro-
vide evidence consistent with a disruption of the
processes supported by these speciﬁc neural locations and in
particular BA10.
Prospective memory tasks may be deﬁned as either
event-based or time-based. For example, some predeﬁned
external event may trigger the retrieval of the intention to
act, or alternatively the trigger may be the elapse of a given
period of time. Self-reported measures do not adequately cap-
ture this distinction and thus while there is evidence of
self-reported ecstasy/polydrug-related deﬁcits in PM it is not
clear whether users exhibit deﬁcits on one or both types of
task. This is an important question since there is evidence to
suggest that the two classes utilize neural processes that are at
least in part separable. For example, Burgess et al. (2003) and
Gilbert et al. (2005) have shown that event-based tasks utilize
the frontopolar cortex, including BA10. More recently posi-
tron emission tomography (PET) scanning has revealed that
while the left superior frontal gyrus was involved in both
types of tasks, diﬀerent areas within this structure were
found to be activated. Furthermore, in addition to the fron-
topolar cortex, the time-based tasks also activated more
diverse regions including anterior medial frontal regions, the
right superior frontal gyrus and the anterior cingulate (Okuda
et al., 2007). Thus, if ecstasy/polydrug users are diﬀerentially
aﬀected on time- and event-based PM tasks then this would
provide further information on which speciﬁc neural loca-
tions are susceptible to speciﬁc drug-related eﬀects.
To address these issues laboratory-based and self-reported
measures of PM and real-world memory were administered.
Ecstasy/polydrug-related deﬁcits were predicted on all
measures.
Method
Participants
Forty-two ecstasy/polydrug users (14 males, 28 females) and
31 non-users (ﬁve males, 26 females) took part in this inves-
tigation. Participants were recruited via direct approach to
university students and the snowball technique, i.e.
word-of-mouth referral (Solowij et al., 1992). All participants
were university students attending Liverpool John Moores
University (LJMU) or the University of Central Lancashire
(UCLAN).
Materials
The prior history of illicit drug consumption was assessed
using a background drug-use questionnaire which has been
used extensively in previous research from our laboratory
(e.g., Montgomery et al., 2005b). These data were used to
estimate the total lifetime use for each drug (e.g. ecstasy,
cannabis, amphetamines, cocaine, etc). Period of abstinence
and frequency of use were also assessed. Fluid intelligence
was measured via Raven’s Progressive Matrices (Raven
et al., 1998) and the number of years of education, the par-
ticipant’s age and gender, and their current use of cigarettes
and alcohol were assessed.
Self-reported measures of real-world memory
Everyday memory: The Everyday Memory Questionnaire
(EMQ) (Cornish, 2000; Sunderland et al., 1983) is a
self-reported measure of memory lapses in everyday activities.
The measure consists of 27 statements with responses made
on a nine-point scale ranging from ‘not at all in the last six
months’ to ‘more than once a day’. Examples of statements
include: ‘forgetting where you put something’; ‘ﬁnding a tele-
vision story diﬃcult to follow’. A total score is calculated by
summing the responses to all items.
Cognitive failures: The Cognitive Failures Questionnaire
(CFQ) (Broadbent et al., 1982) is a 25-item measure of every-
day attentional deﬁcits. Questions include ‘Do you fail to
notice signposts on the road?’ and ‘Do you forget what you
came to the shops to buy?’. Responses are made on a
ﬁve-point scale with zero corresponding to ‘never’ and four
to ‘very often’ yielding a maximum possible score of 100.
Prospective Memory Questionnaire: The Prospective
Memory Questionnaire (PMQ) (Hannon et al., 1995) is a
self-reported measure indicating the likelihood of a memory
lapse in given time period. The PMQ provides measures of
three aspects of PM on a scale of 1–9 for each aspect (1
revealing little forgetting, 9 revealing a great deal of forget-
ting). Fourteen questions measure short-term habitual PM,
e.g. ‘I forgot to turn my alarm clock oﬀ when I got up this
morning’. Fourteen items measure long-term episodic PM,
e.g. ‘I forgot to pass on a message to someone’. Ten questions
measure internally cued PM, e.g. ‘I forgot what I wanted to
say in the middle of a sentence’. In addition, 14 questions
make up the ‘techniques to remember’ scale, which provides
a measure of the number of strategies used to aid remember-
ing. For each of the four scales, an average score is calculated
by summing the responses and dividing by the number of
items in that section (14 for ST-habitual, LT episodic and
strategies and 10 for internally cued). Thus, higher scores
are indicative of more forgetting and many strategies used
to aid remembering.
The Prospective and Retrospective Memory Questionnaire
(PRMQ): The Prospective and Retrospective Memory
Questionnaire (PRMQ) (Crawford et al., 2003) provides a
measure of memory slips of this kind in everyday life. It con-
sists of 16 items, eight related to PM failures, e.g. ‘Do you
decide to do something in a few minutes’ time and then forget
to do it?’. Participants were asked to say how often these
things happened to them on a ﬁve-point scale, very often,
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quite often, sometimes, rarely, never, resulting in minimum
and maximum possible scores of eight and 40.
The reliability and validity of the CFQ, EMQ and PMQ
have been documented previously (see, for example, Hannon
et al., 1995; Royle and Lincoln, 2008; Wallace, 2004).
Laboratory measures of prospective memory
Prospective memory pattern recognition test: This test is
based on a processing speed task (see, e.g., Fisk and Warr,
1996) which was amended so as to provide a laboratory-based
measure of PM by the addition of a parallel PM element. In
the pattern comparison speed task, participants indicated as
quickly as possible whether two patterns appearing on the
computer screen were the same or diﬀerent by pressing
respectively the ‘/’ key or the ‘Z’ key on the keyboard.
After each 30-second period the patterns increased in com-
plexity and for each level of complexity the computer kept a
record of the number of correct responses. The PM element of
this test required the participant to remember to press the ‘F1’
key at the end of each 30-second period when the message
‘please wait a moment’ appeared. Participants were told that
this was in order to save their scores on the task. Failure to
press F1 resulted in the score for that segment being reported
as an ‘error’ in the screen display at the end of the task. This
task was repeated three times. The number of times the par-
ticipant forgot to press F1 for each trial was calculated pro-
ducing a laboratory event-based PM measure.
Prospective memory fatigue test: At the beginning of the
test session, participants were told that they should provide
an indication of their level of fatigue (using the Karolinska
Sleepiness Scale; see Gillberg et al., 1994) every 20 minutes
throughout the experiment. If the 20-minute period elapsed
during the completion of a task, participants were asked to
complete the fatigue measure immediately after. The percent-
age of occasions on which the participant remembered to
complete the Karolinska sleepiness scale was calculated.
This was done for the ﬁrst and second half of the test session
thereby producing two measures of medium-term time-based
PM. On each occasion, participants who forgot were
reminded to ﬁll in the questionnaire.
Long-term recall prospective memory: A list of 15 words
was presented ﬁve times, orally, using an audio recording
device. At the end of each trial the participant had to write
down as many words as they could recall from the list. No
time constraint was imposed in this regard. A long-term PM
element was added to the recall test. Participants had to
remember to return an answer sheet to the experimenter
with the words that they were able to recall after a delay of
1, 2 and 3 weeks from the time of testing. Three prepaid
envelopes were provided for this purpose. Participants
scored 1 if the envelope was returned and 0 otherwise.
This data was collected separately for each week but the
score was the total number of sheets returned (out of a max-
imum of three).
These laboratory tasks were based on similar
paradigms devised by Mathias and Mansﬁeld (2005) and
Einstein et al. (1995).
Rivermead Behavioural Memory Test (RBMT-II): A full
description of the RBMT-II may be found elsewhere
(Wilson et al., 1999). In the present study only the three sub-
tasks relating to PM were used:
(1) Remembering a hidden belonging. A small object (a pen or
pencil in this study) was requested from the participant
and placed in a speciﬁed location. The participant was
told to remember to retrieve the belonging later doing
so when the examiner said the words: ‘We have now ﬁn-
ished this test’. Participants received a score of two if the
belonging and location was recalled correctly, one if after
a prompt and zero if neither object nor location was
remembered.
(2) Remembering an appointment. A timer was set for 20 min-
utes. The participant was told that when the alarm clock
rang they should ask a pre-arranged question (e.g., ‘What
time does this session end’). A proﬁle score of two is given
if the question is recalled correctly, one if after a prompt
or zero if it is not recalled at all.
(3) Delivering a message. Having ﬁrst observed the experi-
menter, the participant was required to replicate a short
route around the test room depositing a message at a
speciﬁed location on the way. This was done immediately
and after a delay and a single score was awarded ranging
from zero to three depending on the number of errors
made over the two attempts.
Procedure
Participants were informed of the general purpose of
the experiment and their right to withdraw any time.
After consent had been obtained the tests were administered
under laboratory conditions. The drug-use questionnaire
was administered ﬁrst followed by the Ravens intelligence
test, the age/education questionnaire, and the PM question-
naires (Crawford et al., 2003; Hannon et al., 1995). Next
the PM pattern recognition task, the recall PM task and
the RBMT-II tasks were administered. The fatigue PM
task was administered throughout the session. Participants
were fully debriefed, paid 20 in Tesco store vouchers
and given drug education leaﬂets. The University of
Central Lancashire’s Ethics Committee approved the study.
Results
Demographic and background variables
Inspection of Table 1 reveals that the ecstasy/polydrug users
did not diﬀer from non-ecstasy users on most of the demo-
graphic and background drug use variables. Ecstasy/polydrug
users consumed signiﬁcantly more units of alcohol per week
compared with non-ecstasy users. Although the number of
cigarettes consumed per day by smokers did not diﬀer signif-
icantly between the groups, tobacco use was more prevalent
among ecstasy/polydrug users with over one-half of the group
currently smoking while less than one-third of non-ecstasy
users currently smoked cigarettes.
With regard to illicit drug use, a majority of the ecstasy/
polydrug group had in the past or were currently consuming
Hadjiefthyvoulou et al. 3
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cocaine and almost all were cannabis users. Around 40% of
the group were also amphetamine uses. However, the corre-
lation between estimated lifetime use of ecstasy and cannabis,
r¼ 0.041 (p> 0.05, n¼ 39), was not statistically signiﬁcant
while that between lifetime ecstasy and cocaine use
approached signiﬁcance, r¼ 0.332 (p¼ 0.084, n¼ 28).
Estimated lifetime use of cocaine and cannabis was also
not signiﬁcantly related r¼ 0.172 (p> 0.05, n¼ 29). Among
non-ecstasy users the use of illicit drugs was largely
conﬁned to cannabis, although three of the group had also
used cocaine. Given the limited use of cocaine and amphet-
amine among non-ecstasy users it was not meaningful to sta-
tistically analyse group diﬀerences in these substances.
However, ecstasy/polydrug users had signiﬁcantly greater
total lifetime exposure to cannabis compared with
non-ecstasy users.
Laboratory-based prospective memory measures
With regards to the laboratory measures of PM, examination
of Table 2 reveals that ecstasy/polydrug users were impaired
on all but two of the measures. With regard to the time-based
tasks, remembering to complete the fatigue task proved prob-
lematic for ecstasy/polydrug users especially during the
second half of the test session. Overall the completion rate
among ecstasy users was only 51% of that achieved by
non-users. From a longer-term perspective during the three
weeks following testing non-users posted back 77% more
delayed recall response sheets compared with users.
However, on the time-based RMBT-II appointment task,
group diﬀerences were less evident.
With regard to the event-based tasks, although ecstasy/
polydrug users and non-ecstasy users performed similarly
on the RMBT-II message task, ecstasy users performed
worse on the RMBT-II belonging task. Similarly users were
between two and three times more likely to forget to press the
‘F1’ key during the processing speed task.
Multivariate analysis of variance (MANOVA) with the
seven laboratory measures of PM as dependent variables
and ecstasy/polydrug user group between participants
revealed a statistically signiﬁcant eﬀect of group, ¼ 0.598,
F(7,65)¼ 6.25, p< 0.001, partial g2¼ 0.402. As can be seen
in Table 2, univariate analyses revealed that all but two of
the individual measures yielded statistically signiﬁcant group
diﬀerences with ecstasy/polydrug users consistently perform-
ing worse than non-ecstasy users. Following the inclusion of
covariates relating to lifetime cannabis use (joints) and fre-
quency of cannabis use (times per week), the multivariate
group eﬀect remained statistically signiﬁcant, ¼ 0.671,
F(7,62)¼ 4.34, p< 0.001, partial g2¼ 0.329. Following
the inclusion of two further covariates relating to alcohol
consumption (units per week) and tobacco use (cigarettes
per day), again the multivariate group eﬀect was signiﬁ-
cant, ¼ 0.712, F(7,58)¼ 3.34, p< 0.01, partial g2¼ 0.288.
Table 1. Demographical and background drug use variables for users and non-users
Ecstasy/polydrug users Non-ecstasy users
Mean SD n Mean SD n p-value
Age (years) 21.67 3.61 42 21.03 3.25 31 ns
Ravens Progressive Matrices (maximum 60) 43.32 10.90 42 44.87 7.57 31 ns
Years of Education 15.05 3.15 42 15.63 1.57 31 ns
Cigarettes per day 9.45 8.60 22 6.33 6.65 9 ns
Alcohol (Units per week) 14.85 10.11 41 7.17 8.28 30 <0.01
Total Use
Ecstasy (Tablets) 668.88 1234.67 42 – – – –
Amphetamine (grams) 196.00 254.78 13 – – – –
Cannabis (joints) 3259.49 4571.12 39 243.00 323.14 10 <0.001
Cocaine (lines) 1270.71 1762.69 28 255.00 343.65 2 –
Frequency of Use (times per week)
Ecstasy 0.25 0.32 42 – – – –
Amphetamine 0.10 0.27 14 – – – –
Cannabis 1.02 1.79 39 0.85 1.59 10 ns
Cocaine 0.41 0.51 27 0.54 0.65 2 –
Weeks Since Last Usea
Ecstasy 4 26 42 – – – –
Amphetamine 46 254 16 – – – –
Cannabis 2 23 39 18 154 10 ns
Cocaine 4 18.5 32 8 5 3 –
Number Ever Used
Amphetamine 17 0
Cannabis 40 10
Cocaine 33 3
Ecstasy 42 0
aFor weeks since last use, median and inter-quartile range are reported.
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Thus, the inclusion of the four covariates reduced the ecstasy/
polydrug user group eﬀect size by 28%. However, none of the
covariates were statistically signiﬁcant as predictors of the
dependent variables, F< 1.20, for the multivariate eﬀect, in
all cases. Inspection of Table 2 reveals that in univariate terms
four of the seven dependent variables produced statistically
signiﬁcant group diﬀerences following inclusion of the covari-
ates. Thus, with regard to the laboratory measures, ecstasy/
polydrug users remained impaired relative to non-ecstasy
users even following the inclusion of the covariates. This sug-
gests that the deﬁcits among this group are more likely to be
attributable to ecstasy.
Self-reported real-world memory measures
Outcomes for the self-reported measures of real-world
memory may be found in Table 2. With just one exception,
it is clear that ecstasy/polydrug users exhibit higher scores on
all of the measures consistent with a greater incidence of
real-world memory problems. MANOVA with the seven
self-reported measures of real-world memory as dependent
variables and ecstasy user group between participants
revealed a statistically signiﬁcant eﬀect of group, ¼ 0.756,
F(7,58)¼ 2.68, p< 0.05, partial g2¼ 0.244. Inspection of
Table 2 reveals that in terms of the univariate analyses, the
diﬀerence between the two groups was statistically signiﬁcant
for four of the seven dependent variables. The inclusion of the
two measures of cannabis use as covariates reduced the multi-
variate eﬀect to borderline signiﬁcance, ¼ 0.786,
F(7,56)¼ 2.18, p¼ 0.05, partial g2¼ 0.214. Furthermore
when all four covariates were included (the two measures of
cannabis use plus the tobacco and alcohol use indicators) the
multivariate eﬀect was no longer statistically signiﬁcant
¼ 0.826, F(7,52)¼ 1.57, p> 0.05, partial g2¼ 0.174 and
inspection of Table 2 reveals that only one of the univariate
analyses continued to yield a statistically signiﬁcant group
diﬀerence: the everyday memory measure. In multivariate
terms, two of the four covariates produced a statistically sig-
niﬁcant eﬀect on the self-reported real-world memory mea-
sures, total cannabis use, ¼ 0.769, F(7,52)¼ 2.23, p< 0.05,
partial g2¼ 0.231; and tobacco use ¼ 0.723, F(7,52)¼ 2.84,
p< 0.05, partial g2¼ 0.277.
Relationship between period of abstinence and
memory
It is possible that some of the drug-related deﬁcits observed in
the real-world memory measures may have been due to
short-term post-intoxication eﬀects. For the four main illicit
drugs, Table 3 contains the correlations between weeks since
last use and each of the real-world memory measures.
Inspection of Table 3 reveals that for the most part the cor-
relations not were statistically signiﬁcant. With regard to the
cognitive failures measure, although no ecstasy/polydrug
eﬀect was evident in Table 2, it is clear that performance on
the task is correlated with the period of abstinence speciﬁcally
in relation to ecstasy. Those abstaining for a longer period
self-reported fewer cognitive failures.
Table 2. Scores on laboratory and self-reported measures of real-world memory for users and non-users
Ecstasy/polydrug users Non-ecstasy users
p p
Mean SD Mean SD p-value
Covariates:
cannabis
use
Covariates:
cannabis smoking,
and alcohol use
LABORATORY MEASURES
RBMT-II
Appointment 1.55 0.77 1.65 0.61 ns ns ns
Belonging 1.19 0.77 1.65 0.62 <0.01 <0.05 <0.05
Message 1.83 0.50 1.87 0.50 ns ns ns
Fatigue PM Task (% recalled)
First half of test session 50.44 36.04 72.20 25.57 <0.01 <0.01 <0.05
Second half of test session 9.48 16.26 44.62 39.52 <0.001 <0.001 <0.001
Processing Speed PM Task Errors 1.64 2.55 0.61 1.23 <0.05 <0.05 <0.05
Long-term Recall PM Task (max 3) 0.95 1.32 1.68 1.30 <0.05 ns ns
SELF-REPORTED MEASURES
Everyday Memory 94.51 36.13 79.42 31.77 <0.05 <0.05 <0.05
Prospective Memory
(Hannon et al., 1995)
Short Term 1.53 0.72 1.27 0.38 <0.05 <0.05 ns
Long Term 2.81 1.00 2.47 0.88 ns ns ns
Internally Cued 2.62 0.96 2.39 0.95 ns ns ns
Techniques to Remember 2.74 1.10 3.32 1.58 <0.05 ns ns
Cognitive Failures 43.40 14.20 40.00 12.71 ns ns ns
Prospective Memory
(Crawford et al., 2003)
22.63 4.96 20.56 5.52 <.05 <.05 Ns
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Relationship between aspects of drug use and the
memory measures
Table 4 contains the simple Pearson’s correlation coeﬃcients
between the laboratory and self-reported measures of
real-world memory on the one hand and lifetime use and
frequency of use of the four main illicit drugs on the other
(for non-users of a particular drug, lifetime and frequency of
use have been coded as zero). Only those correlations that
were statistically signiﬁcant at p< 0.05 one-tailed are dis-
played. Examination of Table 4 reveals that total lifetime
use of both ecstasy and cocaine are related to several of the
laboratory measures indicating that as the level use increases,
the real-world memory deﬁcits increase in magnitude. With
regard to frequency of use, cocaine is signiﬁcantly correlated
with ﬁve of the seven laboratory measures of real-world
memory while the frequency of ecstasy use is signiﬁcantly
correlated with just three. In all cases increased frequency
of use is associated with a greater degree of memory impair-
ment. While the deﬁning characteristic of the polydrug group
is ecstasy use, clearly it appears that cocaine is also implicated
in the real-world memory deﬁcits identiﬁed here.
With regards to the self-reported measures of real-world
memory, correlations with lifetime use are generally larger in
absolute magnitude for ecstasy compared with cocaine.
Similarly, in relation to frequency of use, while ecstasy
yields signiﬁcant correlations for three of the real-world
memory measures, only one is statistically signiﬁcant in rela-
tion to cocaine use. For all of the statistically signiﬁcant cor-
relations, increased use is associated with higher scores on the
self-reported measures consistent with more real-world
memory problems.
While it would have been potentially informative to con-
duct regression analyses with the measures of lifetime use and
frequency of use for each drug as predictors and the measures
of real-world memory as dependent variables, this was not
possible. The sample size was inadequate given the number
of predictors and the predictors were substantially intercorre-
lated reﬂecting the degree of polysubstance abuse within the
ecstasy/polydrug group. Indeed all but two of the predictors
possessed tolerances of less than 0.5 rendering testing and
interpretation of the regression coeﬃcients problematic
(Tabachnick and Fidell, 2001).
However, while the standardized regression coeﬃcients are
not especially informative in the present context, a compari-
son of the simple correlation and semi-partial correlation
coeﬃcients does provide an indication of which variables
share statistically signiﬁcant unique variance with the
real-world memory measures. Thus, where the simple correla-
tions were statistically signiﬁcant the semi-partial correlation
between that drug-use measure and the real-world memory
performance was computed controlling for the use of the
other drugs on the measure in question. Thus, in relation to
the RBMT-II belonging measure lifetime and frequency of
cocaine use appear to be important determinants. For the
RBMT-II message measure the frequency of cannabis use,
and for the long-term recall PM task the frequency of both
cocaine and cannabis use account for statistically signiﬁcant
unique variance. Of the self-reported measures lifetime
ecstasy use is signiﬁcantly associated with unique variance
in the short-term and internally cued Hannon et al. (1995)
PM measures and frequency of ecstasy use with the cognitive
failures measure. The frequency of cannabis use shares unique
variance with the short-term PM measure.
Table 3. Correlations between real-world memory measures and duration of abstinence for the major illicit drugs
Weeks since last use
Ecstasy Cannabis Cocaine Amphetamine
LABORATORY MEASURES
RBMT-II
Appointment 0.089 0.025 0.001 0.526*
Belonging 0.137 0.082 0.030 0.078
Message 0.001 0.175 0.066 0.212
Fatigue PM Task (% recalled)
First half of test session 0.336* 0.281 0.248 0.405
Second half of test session 0.113 0.124 0.128 0.192
Processing Speed PM Task Errors 0.037 0.182 0.029 0.174
Long-term Recall PM Task (max 3) 0.174 0.025 0.074 0.011
SELF-REPORTED MEASURES
Everyday Memory 0.028 0.048 0.126 0.243
Prospective Memory (Hannon et al., 1995)
Short Term 0.119 0.043 0.165 0.210
Long Term 0.034 0.023 0.033 0.154
Internally Cued 0.044 0.155 0.027 0.043
Techniques to Remember 0.024 0.110 0.084 0.218
Cognitive Failures 0.556*** 0.147 0.070 0.305
Prospective Memory (Crawford et al., 2003) 0.151 0.113 0.026 0.119
***p< 0.001; *p< 0.05 one-tailed.
6 Journal of Psychopharmacology 0(00)
 at University of Central Lancashire on September 6, 2011jop.sagepub.comDownloaded from 
Semi-partial correlation is a conservative procedure in
which the pooled variance between the real-world memory
measure and two or more of the drug-use variables is
excluded. For a number of the real-world memory measures
some of the simple correlations with drug use were statisti-
cally signiﬁcant while none of the semi-partial correlations
proved to be so. Thus, in these cases there is a signiﬁcant
drug-related eﬀect but it is not possible to identify which
drug was likely to be primarily responsible. For example,
with respect to processing speed task PM errors, total use
of ecstasy yields a correlation of 0.284, which implies that
the shared variance between the two measures was over
8%. However following control for total use of the other
drugs, the semi-partial correlation was reduced to 0.177,
implying that total ecstasy use shared just over 3% of the
variance with the processing speed task PM errors measure
after the overlapping eﬀects of the other drugs were elimi-
nated. The equivalent ﬁgures for total use of cocaine were
8% and 2%. Thus, in this case, while there is evidence of
potential cocaine and ecstasy-related eﬀects, similar patterns
of use for these two drugs in those persons exhibiting diﬀerent
degrees of PM deﬁcits make it impossible to identify which
drug may be associated with outcomes on this PM measure.
Inter-correlations between the prospective memory and
real-world memory measures
Ignoring for the moment drug-related diﬀerences, it would be
reasonable to expect that the laboratory measures of PM
would be correlated with each other. However, the correla-
tions would not be expected to be perfect since each task
would have performance aspects speciﬁc to it. Furthermore,
the separate tasks reﬂect diﬀerent aspects of PM functioning
such as event-based versus time-based tasks and in the latter
case PM deﬁcits may be reﬂected with respect to both
short-term and longer-term phenomena. Inspection of
Table 5 reveals that with the exception of the long-term
Table 4. Correlations between real-world memory measures and lifetime use and frequency of use for the major illicit drugs
Lifetime Use Frequency
Real-world Memory Measure Drug Simple Semi Partial Simple Semi Partial
Laboratory Measures
RBMT-II
Appointment Cocaine 0.258* 0.288* 0.265* 0.210y
Belonging Ecstasy 0.300** 0.106
Cannabis 0.233* 0.052
Cocaine 0.408*** 0.238* 0.482*** 0.440***
Message Cannabis 0.264* 0.273*
Fatigue PM Task (% recalled)
First half of test session Ecstasy 0.238* 0.163y
Cannabis 0.203* 0.124 0.247* 0.203y
Cocaine 0.204* 0.072 0.244* 0.101
Second half of test session Ecstasy 0.231* 0.118 0.267* 0.167y
Cannabis 0.254* 0.178y
Cocaine 0.213* 0.033
Processing Speed PM Task Errors Ecstasy 0.284* 0.177y 0.227* 0.143
Cocaine 0.283* 0.146 0.277* 0.154
Long-term Recall PM Task (max 3) Cannabis 0.276* 0.173y 0.260* 0.207*
Cocaine 0.254* 0.161 0.330** 0.271*
Self-Reported Measures
Everyday Memory
Prospective Memory (Hannon et al., 1995)
Short Term Ecstasy 0.304** 0.279*
Cannabis 0.265* 0.218*
Long Term
Internally Cued Ecstasy 0.377** 0.361** 0.271* 0.181y
Amphetamine 0.249* 0.127
Techniques to Remember
Cognitive Failures Ecstasy 0.292* 0.212y 0.350** 0.251*
Cocaine 0.237* 0.027
Cannabis 0.251* 0.038
Prospective Memory (Crawford et al., 2003) Ecstasy 0.330** 0.188y 0.253* 0.100
Cocaine 0.249* 0.097
Amphetamine 0.229* 0.183y
***p< 0.001; **p< 0.01; *p< 0.05; yp< 0.10; one-tailed.
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recall task, where two of the outcomes only approached sig-
niﬁcance, the remaining laboratory tasks did reveal a number
of statistically signiﬁcant inter-correlations. Furthermore, for
each of the laboratory tasks performance was correlated with
the scores obtained on one or more of the self-reported mea-
sures. Finally, not surprisingly, Table 6 reveals that the out-
comes for the self-reported measures were also correlated
with each other.
Discussion
In multivariate terms ecstasy/polydrug users were found to be
impaired on the laboratory-based PM measures. The
group-related eﬀect remained statistically signiﬁcant follow-
ing controls for lifetime and frequency of cannabis use and
current use of tobacco and alcohol. In terms of the individual
laboratory measures, ecstasy/polydrug users exhibited poorer
performance in all cases. These deﬁcits were statistically sig-
niﬁcant on all but two of the measures (the two exceptions
were the RBMT appointment and message subscales) and
remained statistically signiﬁcant in four of the seven measures
following controls for cannabis, alcohol and tobacco use. In
demonstrating that ecstasy/polydrug users were impaired on a
variety of PM tasks the present study extends previous
research in which ecstasy users have been found to exhibit
impairment on a range of cognitive tasks, for example, selec-
tive deﬁcits have been observed in aspects of verbal and
visuospatial executive functioning, on the Tower of Hanoi,
and Tower of London tasks, as well as on the Stroop measure
(for a review, see Murphy et al., 2009). Ecstasy users have also
exhibited performance decrements in aspects of deductive rea-
soning (Fisk et al., 2005).
Table 5. Inter-correlations between the laboratory and self-reported measures of real-world memory
RBMT-II Fatigue PM Task
Processing
Speed PM Task
Long-term
Recall PM Task
Appointment Belonging Message First Half Second Half
LABORATORY MEASURES
RBMT-II
Appointment
Belonging 0.334**
Message 0.021 0.200*
Fatigue PM Task (% recalled)
First half of test session 0.238* 0.291** 0.056
Second half of test session 0.266* 0.263* 0.122 0.425***
Processing Speed PM Task Errors 0.220* 0.270* 0.049 0.206* 0.185y
Long-term Recall PM Task (max 3) 0.026 0.190y 0.060 0.073 0.028 0.182y
SELF-REPORTED MEASURES
Everyday Memory 0.018 0.041 0.140 0.063 0.141 0.033 0.094
Prospective Memory (Hannon et al., 1995)
Short Term 0.096 0.128 0.003 0.230* 0.120 0.392*** 0.135
Long Term 0.069 0.155 0.139 0.053 0.312** 0.006 0.096
Internally Cued 0.021 0.037 0.014 0.077 0.175y 0.024 0.046
Techniques to Remember 0.041 0.072 0.048 0.024 0.002 0.035 0.241*
Cognitive Failures 0.174y 0.161y 0.007 0.223* 0.323** 0.108 0.044
Prospective Memory (Crawford et al., 2003) 0.279** 0.190y 0.003 0.201* 0.281** 0.008 0.048
***p< .001; **p< .01; *p< .05; yp< .10; one-tailed.
Table 6. Inter-correlations between the self-reported measures of real-world memory
Everyday
Prospective Memory
Cognitive
Memory Short Term Long Term Internally Cued Techniques Failures
SELF-REPORTED MEASURES
Everyday Memory
Prospective Memory (Hannon et al., 1995)
Short Term 0.049
Long Term 0.442*** 0.246*
Internally Cued 0.455*** 0.379*** 0.507***
Techniques to Remember 0.254* 0.211* 0.366** 0.577***
Cognitive Failures 0.477*** 0.280** 0.357** 0.513*** 0.289**
Prospective Memory (Crawford et al., 2003) 0.615*** 0.145 0.412*** 0.521*** 0.328** 0.707***
***p< 0.001; **p< 0.01; *p< 0.05; one-tailed.
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Returning to the ﬁndings of the present study, with regard
to the RBMT-II, only the belonging sub-scale yielded statis-
tically signiﬁcant group diﬀerences. To the best of our knowl-
edge the present study is the ﬁrst to demonstrate a deﬁcit on
the RBMT belonging scale (ecstasy users scored lower on this
scale in Zakzanis et al.’s (2003) study, however the diﬀerence
was not statistically signiﬁcant). There have been few studies
investigating ecstasy-related deﬁcits on the RBMT PM mea-
sures. Zakzanis et al. (2003) observed ecstasy-related deﬁcits
on the ‘appointment’ and ‘message’ PM RBMT component
measures while neither of these yielded statistically signiﬁcant
diﬀerences in the present study. It is possible that the deﬁcits
observed by Zakzanis et al. (2003) might have been due to
confounding factors. For example, their ecstasy users scored
signiﬁcantly lower on the WAIS-III vocabulary sub-test com-
pared with the control group.
The three remaining laboratory-based tasks, i.e. the fati-
gue PM task (remembering to periodically complete the fati-
gue measure during the test session), the processing speed PM
task (remembering to press ‘F1’ to store the participant’s
scores), and the long-term recall PM task (remembering to
mail the delayed recall test in the successive weeks following
the test session) all yielded consistent ecstasy/
polydrug-related deﬁcits which for the most part remained
statistically signiﬁcant following the inclusion of the covari-
ates. Furthermore, deﬁcits were evident on both time-based
(fatigue PM task) and event-based PM tasks (RBMT-II
belonging; processing speed PM task) which suggests that
the ecstasy/polydrug deﬁcit reﬂects some general feature of
PM task performance rather than more task-speciﬁc aspects.
Thus, it appears that some aspects of ecstasy use or some
other characteristic of the ecstasy-using group gives rise to
PM deﬁcits independent of any eﬀects which might be attrib-
utable to cannabis use. This is consistent with the results of
those studies which have used self-reported measures and
have found ecstasy-related deﬁcits, for example, those from
our own laboratory (Montgomery and Fisk, 2007) and else-
where (Heﬀernan et al., 2001a,b; Rodgers et al., 2001, 2003).
The present results suggest that these deﬁcits are likely to be
real rather than imagined and are evident in both time- and
event-based PM contexts. Ecstasy-related deﬁcits were also
evident on both short-term (fatigue) and long-term (weekly
word recall) PM tasks although in the latter case the deﬁcit
was no longer signiﬁcant following controls for group diﬀer-
ences in cannabis use. These results are perhaps somewhat at
odds with those reported by Rodgers et al. (2001, 2003) who
found that, on the basis of self-reports, ecstasy use was asso-
ciated with long-term deﬁcits while cannabis use was asso-
ciated with short-term. While the present study is among
the ﬁrst to use a range of laboratory-based and naturalistic
PM measures, previous research using the ‘virtual week’ par-
adigm did reveal ecstasy-related deﬁcits with users performing
worse than non-users on time- and event-based PM compo-
nents of the task. Furthermore, the deﬁcits were present in
both frequent and infrequent users (Rendell et al., 2007). In a
subsequent study, methamphetamine users also exhibited def-
icits on this task (Rendell et al., 2009). As noted above the
‘virtual week’ is a board game conducted in the laboratory in
which the participant is required to complete previously
learned tasks at speciﬁc points as they progress around the
board. While this test has its merits, before the PM element
can be completed it is necessary to learn each of the particular
responses that is paired with speciﬁc locations on the board.
Thus, the test has a substantial associative learning compo-
nent. Montgomery et al. (2005a) have demonstrated that
ecstasy users are impaired on paired associative learning
and so it is possible that the deﬁcits evident on the virtual
week might be attributable to this aspect rather than the PM
components. In the present study, the retrospective memory
element was minimal and little learning was necessary. Thus,
the PM deﬁcits observed here are less likely to be due to
associative learning problems.
While it is noteworthy that the ecstasy/polydrug group
diﬀerences remained statistically signiﬁcant following the
inclusion of the cannabis use measures as covariates there
are indications that cannabis use may be negatively associated
with PM. For example the frequency of cannabis use
accounted for unique variance in the long-term recall PM
task with more frequent users returning fewer recall answer
sheets in the weeks following testing. Furthermore, while
there was no ecstasy/polydrug-related diﬀerence on the
RBMT message score, the frequency of cannabis use again
was associated with unique variance on this task with more
frequent users achieving lower scores. Furthermore the can-
nabis use measures were signiﬁcantly correlated with a
number of the other laboratory PM tasks with greater lifetime
exposure and increased frequency of use associated with
poorer PM performance. However, in these cases the eﬀects
were reduced to below statistical signiﬁcance when the shared
variance with the other drug use measures was excluded.
Among ecstasy/polydrug users there was clear evidence that
cocaine use was associated with adverse outcomes on a number
of the laboratory tests of PM. As far as the authors are aware
the present study is the ﬁrst to link recreational use of cocaine
with PM deﬁcits. Either lifetime, or frequency of use, or both,
were associated with performance on all but one of the labo-
ratory measures of PM and one or other of these aspects of
use were found to share unique variance with three of the
PM laboratory measures. As noted above PM performance
is dependent on pre-frontal executive resources. Of particular
relevance to the present paper, a number of studies have shown
that event-based PM tasks utilize the frontopolar cortex, i.e.
BA10 (Burgess et al., 2003; Gilbert et al., 2005) and the left
superior frontal gyrus (Okuda et al., 2007). Similarly while
time-based PM tasks activated more diverse regions including
anterior medial frontal regions, the right superior frontal gyrus
and the anterior cingulate, they also utilized BA10 and the
superior frontal gyrus (Okuda et al., 2007). Thus, the
cocaine-related deﬁcits observed on both the time- and
event-based laboratory PM tasks might be arise from the
eﬀects of the drug on the processes supported by BA10.
Neuroimaging studies in normal populations have revealed
that the dorsolateral prefrontal cortex including BA10 sup-
ports a broad range of executive functions and in particular
those which involve updating the contents of working memory
(Collette et al., 2005). This raises the possibility that cocaine
use is associated with speciﬁc executive function deﬁcits which
in turn give rise to PM deﬁcits. Few studies of cocaine users
have focused on this particular component executive process.
Deﬁcits among cocaine users have been observed on the paced
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auditory serial addition task (PASAT) (Berry et al., 1993; but
see also Gonzalez et al., 2004). Furthermore, substance-
dependent polydrug users whose drug of choice was cocaine
were found to be impaired on a number letter re-sequencing
task, and on forward and backward digit and spatial span
(Verdejo-Garcı´a and Pe´rez-Garcı´a, 2007). These tasks all
require the contents of working memory to be updated and
the results are therefore consistent with a cocaine-related def-
icit in the updating component process.
At the neurotransmitter level dopaminergic activity in the
prefrontal cortex is known to underpin executive processes.
Equally cocaine is known to inﬂuence behaviour through its
eﬀects on dopamine expression (Heien et al., 2005;
Sidiropoulou et al., 2009; Zhang et al., 2005). Unifying these
separate aspects, Tomasi et al.’s (2007) fMRI results demon-
strated that compared to controls, cocaine users exhibited
hypoactivation in the mesencephalon, where dopamine cell
bodies are located and projections originate, together with a
deactivation in dopamine projection regions (putamen, ante-
rior cingulate, parahippocampal gyrus and amygdala). These
outcomes were associated with a compensatory hyperactiva-
tion in cortical regions involved with executive functions (pre-
frontal and parietal cortices). However, during the
performance of a task loading on working memory resources
the activation of these prefrontal regions was less than that
observed in non-users. Interestingly, those users with urine
samples positive for cocaine were signiﬁcantly less likely to
exhibit these tendencies relative to abstinent users. Thus,
Tomasi et al. (2007) argue that a prior history of cocaine use
disrupts the operation of those dopaminergic systems in the
prefrontal cortex which underpin executive functioning. One
manifestation of this disruption may be the cocaine-related
deﬁcit in PM functioning which could stem from impairment
to the updating executive process due the possible susceptibil-
ity of BA10 to dopamine-mediated deﬁciency.
A further possibility is that cocaine might give rise to
impairment in medial temporal and hippocampal processes.
Fox et al. (2009) observed deﬁcits in various aspects of per-
formance on the Rey Auditory Verbal Learning Task
(RAVLT) among cocaine-dependent individuals receiving
treatment as inpatients. Deﬁcits in learning and recall were
related to between group self-reported stress levels and among
cocaine users with raised early morning cortisol levels. Fox
et al. argue that the stress-related increase in cortisol levels
and associated memory deﬁcits are potentially symptomatic
of hippocampal damage among cocaine-dependent indivi-
duals. Such deﬁcits might potentially aﬀect the recall compo-
nent of PM performance and if present among recreational
cocaine users might therefore provide an explanation for the
results obtained here.
While the laboratory PM measures demonstrated clear
drug-related eﬀects, outcomes in relation to the self-reported
measures were less clear-cut. Although the ecstasy/polydrug
group exhibited impairment this was substantially attenuated
following the inclusion of the other measures as covariates. It
may be that although ecstasy/polydrug users as a whole are
aware of their PM problems they may be uncertain as to
which illicit drug is responsible for their perceived deﬁcits.
As with most studies in this area, there are a number of
limitations. Owing to the quasi-experimental design of the
study the concurrent use of other illicit drugs may have con-
tributed to group diﬀerences in PM as the two groups also
diﬀered signiﬁcantly on these variables. Also, the purity of
MDMA tablets obviously cannot be guaranteed (but see
Parrott, 2004) and as with previous studies in this area
(Heﬀernan et al., 2001a,b; Morgan, 1999) no objective mea-
sure of recent drug use such as urinalysis was employed.
A further limitation of research of this kind is that the appar-
ent ecstasy/polydrug-related deﬁcits may not necessarily be a
consequence of illicit drug use but perhaps reﬂect some
pre-existing diﬀerence between users and non-users which
had its origins before the initiation of drug use. Consistent
with this possibility, in the context of the longer-term conse-
quences of cannabis use Pope (2002) has emphasized the
importance of considering whether or not the apparent diﬀer-
ences between users and non-users might reﬂect pre-morbid
conditions perhaps in sociodemographic factors, personal dis-
positions, or underlying psychopathology. A further possibil-
ity is that the eﬀects observed here may not have a direct
pharmacological basis but instead be related to lifestyle dif-
ferences or may be due to the eﬀects of drugs on aspects of
physiological functioning, for example sleep quality (but see
Fisk and Montgomery 2009; Montgomery et al., 2007).
To conclude, the current study intended to determine the
impact of ecstasy/polydrug use on aspects of real-world
memory such as everyday memory, cognitive failures and
PM. Ecstasy/polydrug associated deﬁcits were observed on
both laboratory and self-reported measures of PM. Ecstasy/
polydrug users were impaired on all PM laboratory measures
with the exception of one event- and one time-based PM task
from the RBMT-II. Ecstasy/polydrug-related deﬁcits were
also observed in some of the self-reported measures of PM
and in the EMQ while no deﬁcits were observed in the
self-reported measures of cognitive failures. We can therefore
assume that ecstasy/polydrug users possess some self-
awareness of their memory lapses. An unanticipated ﬁnding
was that the recreational use of cocaine can be associated with
PM deﬁcits. Further research is needed to clarify whether the
cocaine-related deﬁcits are limited to the ecstasy/polydrug
population or whether they might be present among those
persons whose recreational use is largely conﬁned to cocaine.
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